Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 4 (MED4) is a protein component of the multiprotein Mediator complex, which functions as a transcriptional coactivator essential for the regulated transcription of virtually all RNA polymerase II-dependent genes. MED4 acts as a bridge linking gene-specific regulatory transcription factors to the basal transcription machinery, facilitating assembly of the preinitiation complex with RNA polymerase II and general transcription factors. MED4 participates in activation of nuclear receptors, such as the vitamin D receptor, as part of the DRIP (vitamin D receptor-interacting protein) complex. In cancer biology, particularly retinoblastoma, MED4 is essential for cell survival when both RB1 alleles are inactivated, making it a synthetic lethal partner and a potential therapeutic vulnerability in tumors lacking RB1. Alternative splicing results in multiple isoforms of MED4.
Not applicable for direct drug targeting; if therapeutically targeted, synthetic lethality in RB1-null environments could be harnessed
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 4 (MED4).